USDA confirmed highly pathogenic avian influenza USDA in dairy herd in New Mexico
On Apr. 1, 2024, the U.S. Department of Agriculture (USDA) confirmed the detection of highly pathogenic avian influenza…
On Apr. 1, 2024, the U.S. Department of Agriculture (USDA) confirmed the detection of highly pathogenic avian influenza…
On Mar. 29, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported an infection with an…
On Mar. 26, 2024, the National Academies of Sciences, Engineering, and Medicine released a report that says that…
On Mar. 26, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) had approved the cobas…
On Mar. 25, 2024, immediately following the first detection of H5N1 in dairy cattle in the Texas panhandle…
On Mar. 20, 2024, the Minnesota Board of Health announced that a Stevens County goat kid (juvenile goat)…
On Mar. 13, 2024, the National Science Board (NSB) published The State of U.S. Science and Engineering 2024,…
On Mar. 12, 2024, the United Nations Inter-agency Group for Child Mortality Estimation (UN IGME) reported that the…
On Mar. 11, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
On Mar. 8, 2024, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
On Feb. 29, 2024, Valneva announced that the U.S. Centers for Disease Control and Preventionメs (CDC) Advisory Committee…
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
On Feb. 28, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
On Feb. 21, 2024, the World Health Organization (WHO) reported that more than half the world’s countries will…
On Feb. 14, 2024, the National Institute of Allergy and Infectious Diseases (NIAID) reported study results that showed…
On Feb. 6, 2024, Oregon Health & Science University (OHSU) announced research that revealed as much as a…
On Feb. 5, 2024, CSL and and Arcturus Therapeutics announced the results of a follow-up analysis of a…
On Jan. 31, 2024, a U.S. Centers for Disease Control and Prevention (CDC) co-authored study published in Influenza…
On Jan. 25, 2024, an historic study out of Scotland showed the real-world impact of vaccines against the…
On Jan. 4, 2024, AstraZeneca Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, was approved in China for the…
On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…
On Dec. 21, 2023, the World Health Organization (WHO) announced that it had prequalified the R21/Matrix-M malaria vaccine…
On Dec. 19, 2023, COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020,…
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
On Dec. 18, 2023, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
On Dec. 18, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced a study that showed…
On Dec. 18, 2023, the Novo Nordisk Foundation announced it was committing up to DKK 1.8 billion (USD…